Related Experiment Videos
Large vessel vasculitis (giant cell arteritis, Takayasu arteritis)
1Cleveland Clinic Foundation, Department of Rheumatic and Immunologic Diseases, OH 44195, USA.
Bailliere'S Clinical Rheumatology
|May 1, 1997
Summary
Giant cell arteritis and Takayasu arteritis are distinct large vessel vasculitides. This review covers evolving perceptions, diagnostic approaches, and treatment strategies for these inflammatory conditions.
Area of Science:
- Rheumatology
- Immunology
- Vascular Medicine
Background:
- Giant cell arteritis (GCA) and Takayasu arteritis (TA) are idiopathic, granulomatous diseases affecting large arteries.
- Both conditions share clinical features like constitutional symptoms and systemic inflammation markers.
- They are characterized by indistinguishable inflammation of the arterial wall (pan-arteritis).
Purpose of the Study:
- To review and analyze evolving understanding of GCA and TA.
- To discuss the potential for increased aortic involvement in GCA.
- To explore ethnic and geographic variations in TA presentation and management.
Main Methods:
- Literature review focusing on recent series and case studies.
- Analysis of diagnostic criteria and laboratory utility for GCA and TA.
- Discussion of current and emerging treatment philosophies.
Main Results:
- Aortic involvement in GCA may be more prevalent than previously recognized.
- Variations in TA disease expression exist across different ethnicities and geographic regions.
- The role of inflammatory arthritis in GCA is debated.
Conclusions:
- Updated perspectives on GCA and TA highlight the need for reassessment of diagnostic and therapeutic strategies.
- Understanding disease variations is crucial for effective patient management.
- Laboratory diagnostics play a key role in monitoring disease activity in both GCA and TA.